types and a putative disease locus were estimated using various disease models and the EH program.
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Seven haplotypes, involving one or two markers, and the putative disease locus were examined using an assumed disease allele frequency of 0.01. Of the four 2-locus haplotypes, regardless of penetrance, GABRA6 showed significant LD with the disease locus in the dominant disease model (P = 0.042), as did GABRA1 in the recessive model (P = 0.024). Of the three 3-locus haplotypes, significant LDs were only observed for the GABRA6/A1 pair in the dominant model (P = 0.016), regardless of penetrance. Since the LD between the GABRA6/A1 pair and the disease locus was greater than the individual LDs for the two markers in the dominant model, this suggests that they have an additive effect and that the GABRA6 locus plays a greater part in determining the inheritance mode. These LD findings, together with the association results, suggest that the GABRA6 and GABRA1 genes account for alcohol susceptibility in Han and exert their genetic influences in a somewhat dominant and synergistic fashion. SIR -Obesity is a multifactorial condition most often defined by the body mass index (BMI).
YT
1 Some obese patients have concurrent psychiatric disorders and specific temperamental factors, such as compulsivity, impulsivity and neuroticism, which in turn may contribute to develop tendencies to overeat. Several lines of evidence implicate the serotoninergic system in the development of obesity. Clinical evidence suggests that the selective serotonin reuptake inhibitors (SSRIs) suppress food intake, whereas antagonists have the opposite effect. 2 The serotonin transporter (5-HTT) is the site of action of the SSRIs. A functional polymorphism (5-HTTLPR) has been described in the promoter region of the 5-HTT gene, which consist of a 44 bp insertion ('l' allele) or deletion ('s' allele), which have different transcriptional activities. 3 We analysed the effect of 5-HTTLPR variants on susceptibility to obesity using a family-based method. The sample consisted of 50 obese subjects (33 females and 17 males; mean age 32 ± 9.5 years) and their parents. Obese subjects were from the Weight Control Clinic at the National Institute of Medical Sciences and Nutrition, Mexico City if they had a BMI Ն30 kg m In addition, the presence of impulsivity was assessed using the Plutchik's impulsivity scale Spanish version. 4 All participants provided written informed consent.
Genotyping for the 5-HTTLPR polymorphism was performed using the conditions previously reported 2 and analysed with the transmission disequilibrium test (TDT). 5 TDT analysis did not reveal a preferential transmission from 48 heterozygous parents of obese probands ( 2 TDT = 0.35, P = 0.471) (data not shown). Finally, 65% of obese probands showed presence of impulsivity defined as a Ն15 score on the Plutchik's scale. Analysis by TDT showed in the impulsive females a preferential transmission of allele 'l' from the heterozygous parents, providing significant evidence for allelic association ( 2 TDT = 4.54, P = 0.033) ( Table  1 ). In contrast, there was no statistical evidence of an allelic association when considering obese males with impulsivity and obese females and males without impulsivity (P Ͼ 0.05). Association results without a prior hypothesis should be corrected for a genomicwide screen. In the present study, we only analysed one specific locus and it is not necessary to correct the P-value for multiple testing. 6 In this study, we provide evidence that supports a weak sexually selective association between 5-HTT and obese females with impulsivity. However, our results might be a false positive because of the small sample size. Replication studies will be important to detect this proposed effect using an appropriate sample size.
A previous study did not find a preferential transmission of the 5-HTTLPR variants using TDT, however gender was not included as a variable. 7 Recently, an excess of allele 'l' in overweight patients was reported. 8 Gender differences have been described for eating disorders. Extreme obesity and anorexia nervosa are more common in females. It has been suggested that estrogen increases the expression of the serotonin transporter mRNA and binding sites in female rat brain. 9 In conclusion, the possible contribution of serotonin dysfunction to the pathophysiology of obesity is not definitively established. However, our finding indicates that gender differences in the function of the serotonin system could be relevant as a risk factor for obesity in females, and/or to the development of serotoninergic related psychopathological symptoms such as impulsivity. In any case, these findings must be regarded as tentative until replicated in large samples. 
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